Product category:
Clinical chemistry analysis
News Release from: Perkin Elmer LAS (UK) | Subject: Progenesis PG600
Edited by the Laboratorytalk Editorial
Team on 12 September 2005
Proteomics biomarker discovery moves
forward
System allows researchers to interact with data using a simple and intuitive interface that provides powerful, reproducible and highly reliable biomarker discovery and screening capabilities
PerkinElmer featured at the Human Proteome Organisation (Hupo) 4th annual world congress in Munich, Germany, the Progenesis PG600 biomarker analysis software from Nonlinear Dynamics Combining Nonlinear's expertise in data analysis with PerkinElmer's novel, high-tech solutions in imaging and detection and mass spectrometry, Progenesis PG600 allows researchers to interact with data using a simple and intuitive interface that provides powerful, reproducible and highly reliable biomarker discovery and screening capabilities
This article was originally published on Laboratorytalk on 19 Apr 2002 at 8.00am (UK)
Related stories
Probing the source of diabetes
Newly developed gene probes increase efficiency and speed of research in studies of type 1 (juvenile) diabetes, detecting the presence of alleles by hybridisation reaction
Manage the entire gene expression process
With microarray labs generating more than one million primary data points daily, this gene expression data management software could speed up actual gene and drug discovery
The software is the first proteomics product to be developed through PerkinElmer's recent partnership with Nonlinear.
Progenesis PG600 facilitates the discovery of biomarkers by comparing the mass spectrometry profiles of two or more different sample classes (eg, disease versus healthy, or treated versus untreated) and provides a number of powerful analytical and visualisation tools to aid in the identification of feature differences in data sets.
A customised interface designed for PerkinElmer allows the direct uploading of raw data from PerkinElmer's Protof 2000 orthogonal Maldi-Tof mass spectrometer, part of its Bioxpression biomarker discovery and screening platform, into Progenesis PG600 software.
"The inclusion of Progenesis PG600 Biomarker into our existing Bioxpression platform will enable users to perform rapid identification of biomarker targets and, in turn, their implementation in a clinical environment," said Peter Coggins,president, PerkinElmer Life and Analytical Sciences.
"The Bioxpression platform is designed to aid in the early detection and identification of specific disease states, allowing researchers to monitor the success of a therapy, and in the future may allow therapies to be tailored to the individual patient".
Other PerkinElmer proteomic solutions to be featured at the show include Protof 2000 Maldi O-Tof mass spectrometer for exceptional mass accuracy and stability, Proxpression biomarker kits, carrier protein-based blood biomarker enrichment kits, Proxpress 2D proteomics imaging system, multi-colour fluorescence 2D and 1D gel imager, Proscanarray microarray analysis system, and proteomics-ready microarray scanner and software.
• Perkin Elmer LAS (UK): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
